| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoplasmic Granules | 37 | 2021 | 610 | 9.210 |
Why?
|
| Protein Biosynthesis | 33 | 2020 | 2126 | 4.140 |
Why?
|
| RNA, Transfer | 11 | 2021 | 316 | 2.880 |
Why?
|
| Stress, Physiological | 22 | 2022 | 1403 | 2.690 |
Why?
|
| RNA-Binding Proteins | 26 | 2021 | 1903 | 2.500 |
Why?
|
| Ribonucleoproteins | 14 | 2020 | 381 | 2.280 |
Why?
|
| Eukaryotic Initiation Factor-2 | 18 | 2021 | 190 | 1.930 |
Why?
|
| Ribonuclease, Pancreatic | 7 | 2021 | 154 | 1.860 |
Why?
|
| RNA, Messenger | 38 | 2023 | 13033 | 1.450 |
Why?
|
| RNA Processing, Post-Transcriptional | 10 | 2022 | 436 | 1.410 |
Why?
|
| G-Quadruplexes | 5 | 2023 | 162 | 1.300 |
Why?
|
| Ribosomal Proteins | 5 | 2022 | 360 | 1.260 |
Why?
|
| RNA | 10 | 2023 | 2749 | 1.250 |
Why?
|
| Gene Expression Regulation | 21 | 2021 | 12072 | 1.160 |
Why?
|
| RNA Stability | 9 | 2023 | 321 | 1.070 |
Why?
|
| Peptide Chain Initiation, Translational | 4 | 2020 | 103 | 1.020 |
Why?
|
| RNA Helicases | 6 | 2023 | 142 | 0.990 |
Why?
|
| Polyribosomes | 9 | 2020 | 110 | 0.950 |
Why?
|
| Cytoplasmic Structures | 4 | 2020 | 21 | 0.940 |
Why?
|
| Mitochondrial Proteins | 5 | 2017 | 996 | 0.890 |
Why?
|
| Organelles | 3 | 2020 | 264 | 0.820 |
Why?
|
| Eukaryotic Initiation Factor-4G | 2 | 2020 | 68 | 0.820 |
Why?
|
| DNA Helicases | 5 | 2023 | 859 | 0.800 |
Why?
|
| Poly(A)-Binding Proteins | 5 | 2011 | 36 | 0.800 |
Why?
|
| RNA Interference | 9 | 2016 | 2889 | 0.790 |
Why?
|
| Mammals | 4 | 2020 | 1143 | 0.760 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 2 | 2020 | 19 | 0.750 |
Why?
|
| Arsenites | 12 | 2018 | 66 | 0.730 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2008 | 4420 | 0.700 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2010 | 1990 | 0.680 |
Why?
|
| Inclusion Bodies | 3 | 2007 | 279 | 0.680 |
Why?
|
| Metered Dose Inhalers | 4 | 2006 | 23 | 0.590 |
Why?
|
| Oxidative Stress | 7 | 2016 | 3086 | 0.580 |
Why?
|
| Immediate-Early Proteins | 3 | 2004 | 453 | 0.580 |
Why?
|
| Tristetraprolin | 5 | 2008 | 42 | 0.570 |
Why?
|
| Peptide Initiation Factors | 3 | 2012 | 56 | 0.530 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2009 | 346 | 0.520 |
Why?
|
| Animals | 70 | 2021 | 168757 | 0.520 |
Why?
|
| Phosphoproteins | 3 | 2020 | 2440 | 0.510 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2916 | 0.490 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2023 | 449 | 0.490 |
Why?
|
| RNA, Ribosomal | 3 | 2022 | 246 | 0.490 |
Why?
|
| Aerosol Propellants | 2 | 2003 | 8 | 0.470 |
Why?
|
| COS Cells | 8 | 2016 | 1161 | 0.460 |
Why?
|
| Sodium Selenite | 1 | 2012 | 11 | 0.440 |
Why?
|
| alpha-Globins | 1 | 2012 | 17 | 0.430 |
Why?
|
| Dermatophagoides farinae | 1 | 2012 | 25 | 0.430 |
Why?
|
| Phosphorylation | 14 | 2019 | 8436 | 0.420 |
Why?
|
| RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2011 | 3 | 0.420 |
Why?
|
| Mitochondria | 5 | 2018 | 3520 | 0.410 |
Why?
|
| Carrier Proteins | 7 | 2019 | 5021 | 0.410 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 769 | 0.410 |
Why?
|
| Amyloid | 1 | 2016 | 795 | 0.400 |
Why?
|
| Vena Cava, Inferior | 1 | 2014 | 440 | 0.400 |
Why?
|
| Health | 1 | 2014 | 394 | 0.390 |
Why?
|
| Disease | 2 | 2014 | 680 | 0.390 |
Why?
|
| Cytokines | 9 | 2021 | 7322 | 0.380 |
Why?
|
| HeLa Cells | 12 | 2022 | 3128 | 0.380 |
Why?
|
| Erythroid Cells | 1 | 2012 | 238 | 0.370 |
Why?
|
| Eukaryotic Initiation Factor-4F | 4 | 2020 | 41 | 0.360 |
Why?
|
| Cell Line | 18 | 2021 | 15997 | 0.360 |
Why?
|
| Cell Respiration | 1 | 2010 | 201 | 0.360 |
Why?
|
| Regulon | 1 | 2010 | 69 | 0.350 |
Why?
|
| Alternative Splicing | 2 | 2020 | 1117 | 0.330 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 731 | 0.330 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2010 | 274 | 0.320 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2010 | 437 | 0.310 |
Why?
|
| Phase Transition | 2 | 2018 | 74 | 0.310 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 941 | 0.310 |
Why?
|
| Erythropoiesis | 1 | 2012 | 705 | 0.310 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2005 | 139 | 0.310 |
Why?
|
| Chlorofluorocarbons | 2 | 2005 | 12 | 0.310 |
Why?
|
| Transcription, Genetic | 5 | 2022 | 7722 | 0.300 |
Why?
|
| Eosinophilia | 1 | 2012 | 541 | 0.300 |
Why?
|
| Drug Labeling | 1 | 2009 | 233 | 0.300 |
Why?
|
| Immunity, Innate | 2 | 2021 | 2958 | 0.290 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3462 | 0.290 |
Why?
|
| Acetylglucosamine | 1 | 2008 | 191 | 0.290 |
Why?
|
| 14-3-3 Proteins | 2 | 2006 | 214 | 0.290 |
Why?
|
| Th2 Cells | 1 | 2012 | 1061 | 0.290 |
Why?
|
| Humans | 93 | 2023 | 744343 | 0.280 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 329 | 0.270 |
Why?
|
| RNA, Transfer, Met | 2 | 2002 | 14 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2005 | 595 | 0.260 |
Why?
|
| Models, Biological | 10 | 2016 | 9583 | 0.260 |
Why?
|
| Th17 Cells | 1 | 2012 | 766 | 0.260 |
Why?
|
| Gene Silencing | 3 | 2007 | 1538 | 0.260 |
Why?
|
| Macrophages, Peritoneal | 2 | 2004 | 251 | 0.260 |
Why?
|
| Mice | 34 | 2021 | 81183 | 0.260 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 336 | 0.250 |
Why?
|
| Lymphocytes | 1 | 2013 | 2617 | 0.250 |
Why?
|
| RNA Caps | 2 | 2020 | 74 | 0.250 |
Why?
|
| Osteosarcoma | 2 | 2010 | 881 | 0.250 |
Why?
|
| 3' Untranslated Regions | 4 | 2015 | 513 | 0.250 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1177 | 0.250 |
Why?
|
| Guanosine Triphosphate | 2 | 2002 | 321 | 0.240 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 32 | 0.240 |
Why?
|
| Response Elements | 1 | 2006 | 312 | 0.240 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 2016 | 40 | 0.240 |
Why?
|
| Ribosomes | 3 | 2022 | 500 | 0.240 |
Why?
|
| Beclomethasone | 1 | 2003 | 38 | 0.240 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2003 | 39 | 0.240 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 16689 | 0.230 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2020 | 1414 | 0.230 |
Why?
|
| Genome | 2 | 2012 | 1808 | 0.230 |
Why?
|
| Quinones | 1 | 2003 | 76 | 0.220 |
Why?
|
| Proteins | 4 | 2017 | 6103 | 0.220 |
Why?
|
| RNA, Untranslated | 2 | 2020 | 453 | 0.220 |
Why?
|
| Endoribonucleases | 3 | 2020 | 229 | 0.220 |
Why?
|
| Prions | 1 | 2004 | 180 | 0.220 |
Why?
|
| Microscopy | 1 | 2008 | 903 | 0.210 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9648 | 0.210 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1200 | 0.210 |
Why?
|
| RNA, Small Interfering | 6 | 2015 | 3505 | 0.210 |
Why?
|
| Isoenzymes | 2 | 2004 | 1726 | 0.210 |
Why?
|
| eIF-2 Kinase | 3 | 2021 | 149 | 0.210 |
Why?
|
| Albuterol | 1 | 2003 | 208 | 0.200 |
Why?
|
| Arthritis | 2 | 2004 | 659 | 0.200 |
Why?
|
| Transfection | 5 | 2017 | 5892 | 0.200 |
Why?
|
| Basal Metabolism | 1 | 2002 | 168 | 0.200 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2133 | 0.190 |
Why?
|
| Inflammation | 4 | 2010 | 10638 | 0.190 |
Why?
|
| Cells, Cultured | 10 | 2020 | 19229 | 0.190 |
Why?
|
| Homeostasis | 1 | 2012 | 3340 | 0.190 |
Why?
|
| Cytoplasm | 4 | 2020 | 1539 | 0.190 |
Why?
|
| Protein Phosphatase 1 | 1 | 2021 | 137 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2020 | 23403 | 0.190 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 72 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2012 | 4560 | 0.180 |
Why?
|
| Sumoylation | 1 | 2020 | 83 | 0.180 |
Why?
|
| Pneumonia | 1 | 2012 | 2133 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 4 | 2012 | 1655 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8428 | 0.180 |
Why?
|
| Nucleic Acid Conformation | 3 | 2020 | 913 | 0.170 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2021 | 282 | 0.170 |
Why?
|
| Protein Binding | 7 | 2017 | 9386 | 0.170 |
Why?
|
| Membrane Proteins | 4 | 2004 | 7880 | 0.170 |
Why?
|
| Muscle Cells | 1 | 2020 | 197 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2021 | 2752 | 0.170 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 692 | 0.170 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 101 | 0.170 |
Why?
|
| Dipeptides | 2 | 2020 | 409 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 2219 | 0.160 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 64 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 9274 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1434 | 0.160 |
Why?
|
| Epoxy Compounds | 2 | 2010 | 136 | 0.150 |
Why?
|
| Anticodon | 2 | 2014 | 25 | 0.150 |
Why?
|
| Base Sequence | 5 | 2016 | 12797 | 0.150 |
Why?
|
| Avoidance Learning | 1 | 2019 | 233 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 3846 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.150 |
Why?
|
| Xenopus Proteins | 1 | 2020 | 433 | 0.150 |
Why?
|
| Macrolides | 2 | 2010 | 201 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2007 | 2924 | 0.150 |
Why?
|
| Phenols | 1 | 2021 | 497 | 0.140 |
Why?
|
| Vinca Alkaloids | 1 | 2016 | 35 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2016 | 20 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1580 | 0.140 |
Why?
|
| Autoantigens | 2 | 2016 | 892 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 3647 | 0.140 |
Why?
|
| Asthma | 4 | 2012 | 6011 | 0.130 |
Why?
|
| Microscopy, Video | 1 | 2016 | 245 | 0.130 |
Why?
|
| Blotting, Western | 4 | 2010 | 5179 | 0.130 |
Why?
|
| Apoptosis | 6 | 2018 | 9727 | 0.130 |
Why?
|
| Fibroblasts | 5 | 2018 | 4161 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 2 | 2012 | 100 | 0.130 |
Why?
|
| Precipitin Tests | 3 | 2004 | 829 | 0.130 |
Why?
|
| Antirheumatic Agents | 1 | 2005 | 1339 | 0.130 |
Why?
|
| Glucocorticoids | 2 | 2005 | 2107 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2282 | 0.130 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 13815 | 0.130 |
Why?
|
| Mice, Knockout | 7 | 2016 | 14557 | 0.120 |
Why?
|
| Physicians | 2 | 2011 | 4567 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 3923 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2017 | 248 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 6314 | 0.120 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 845 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3129 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2005 | 3023 | 0.120 |
Why?
|
| Allergens | 2 | 2012 | 1320 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 474 | 0.110 |
Why?
|
| Sodium Compounds | 3 | 2018 | 30 | 0.110 |
Why?
|
| Lung | 1 | 2012 | 9856 | 0.110 |
Why?
|
| Arginine | 1 | 2017 | 944 | 0.110 |
Why?
|
| Cells | 1 | 2014 | 168 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1157 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 1970 | 0.110 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 2569 | 0.110 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.110 |
Why?
|
| Autoantibodies | 2 | 2016 | 2035 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 4 | 2021 | 2699 | 0.100 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 323 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2006 | 3047 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
| Teratogens | 2 | 2010 | 112 | 0.100 |
Why?
|
| Administration, Inhalation | 2 | 2005 | 1105 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2020 | 3206 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 1888 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 1703 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 124 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21827 | 0.100 |
Why?
|
| Protein Methyltransferases | 1 | 2010 | 55 | 0.100 |
Why?
|
| Thiazoles | 2 | 2010 | 1483 | 0.100 |
Why?
|
| Acylation | 1 | 2010 | 107 | 0.100 |
Why?
|
| Tryptases | 1 | 2012 | 190 | 0.090 |
Why?
|
| Administration, Intranasal | 1 | 2012 | 446 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 2513 | 0.090 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2010 | 12 | 0.090 |
Why?
|
| Chimera | 1 | 2012 | 485 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2012 | 2969 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 697 | 0.090 |
Why?
|
| Fear | 1 | 2019 | 1440 | 0.090 |
Why?
|
| Alprostadil | 1 | 2010 | 89 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13695 | 0.090 |
Why?
|
| Lysine | 2 | 2016 | 1007 | 0.090 |
Why?
|
| Protein Transport | 2 | 2006 | 1988 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 291 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2132 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2014 | 689 | 0.090 |
Why?
|
| Macromolecular Substances | 2 | 2002 | 1454 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2016 | 18111 | 0.090 |
Why?
|
| Acetyltransferases | 1 | 2010 | 234 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 2077 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 3712 | 0.090 |
Why?
|
| Fibrin | 1 | 2012 | 506 | 0.090 |
Why?
|
| Thrombin | 1 | 2012 | 598 | 0.090 |
Why?
|
| Immunoglobulin E | 2 | 2012 | 1463 | 0.080 |
Why?
|
| Goblet Cells | 1 | 2012 | 287 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 6386 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 2011 | 388 | 0.080 |
Why?
|
| Equipment Design | 3 | 2006 | 3582 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 9734 | 0.080 |
Why?
|
| Macrophages | 4 | 2008 | 5655 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2005 | 12208 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2009 | 251 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 894 | 0.080 |
Why?
|
| Cell Survival | 5 | 2018 | 5882 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2009 | 165 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2016 | 4011 | 0.080 |
Why?
|
| Lipopolysaccharides | 3 | 2006 | 2216 | 0.080 |
Why?
|
| Methylation | 1 | 2010 | 1106 | 0.080 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 390 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2007 | 53 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 264 | 0.080 |
Why?
|
| Dust | 1 | 2010 | 482 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 675 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2009 | 1060 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1866 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2017 | 3701 | 0.070 |
Why?
|
| Yeasts | 1 | 2007 | 285 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2007 | 188 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 380 | 0.070 |
Why?
|
| Killer Cells, Natural | 2 | 2006 | 2133 | 0.070 |
Why?
|
| Alphavirus | 1 | 2005 | 9 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1127 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3920 | 0.070 |
Why?
|
| Powders | 1 | 2005 | 80 | 0.070 |
Why?
|
| Neoplasms | 1 | 2014 | 21683 | 0.070 |
Why?
|
| bcl-X Protein | 2 | 2004 | 411 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.070 |
Why?
|
| Pharmacokinetics | 1 | 2005 | 88 | 0.070 |
Why?
|
| Constipation | 1 | 2010 | 546 | 0.060 |
Why?
|
| Ceramics | 1 | 2005 | 105 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 337 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 975 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 834 | 0.060 |
Why?
|
| Drug Design | 1 | 2010 | 1076 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2011 | 696 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2007 | 1663 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6622 | 0.060 |
Why?
|
| Cell Extracts | 1 | 2004 | 138 | 0.060 |
Why?
|
| Heparin | 1 | 2012 | 1637 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 252 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 2 | 2004 | 611 | 0.060 |
Why?
|
| Mast Cells | 1 | 2012 | 1544 | 0.060 |
Why?
|
| Mutation | 6 | 2017 | 29786 | 0.060 |
Why?
|
| Sjogren's Syndrome | 1 | 2006 | 233 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2011 | 1547 | 0.060 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2005 | 536 | 0.060 |
Why?
|
| Uridine | 1 | 2004 | 146 | 0.060 |
Why?
|
| Life Expectancy | 1 | 2010 | 1184 | 0.060 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 809 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1240 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 547 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 798 | 0.060 |
Why?
|
| Sendai virus | 1 | 2002 | 21 | 0.060 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2002 | 26 | 0.060 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 442 | 0.060 |
Why?
|
| Heme | 1 | 2005 | 307 | 0.060 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2002 | 36 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2005 | 720 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 1085 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2016 | 2751 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 712 | 0.050 |
Why?
|
| Benzoquinones | 1 | 2003 | 201 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 502 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 404 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 397 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 17446 | 0.050 |
Why?
|
| Kinetics | 1 | 2010 | 6473 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2002 | 313 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 376 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2005 | 959 | 0.050 |
Why?
|
| Osteoblasts | 2 | 2018 | 1166 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1124 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 1584 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2004 | 527 | 0.050 |
Why?
|
| Neutrophils | 2 | 2004 | 3719 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 634 | 0.050 |
Why?
|
| Glaucoma | 1 | 2011 | 1159 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 2031 | 0.050 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 101 | 0.050 |
Why?
|
| Particle Size | 1 | 2005 | 1642 | 0.050 |
Why?
|
| Lactams, Macrocyclic | 1 | 2003 | 320 | 0.050 |
Why?
|
| Aerosols | 1 | 2003 | 625 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2017 | 1801 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2072 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2005 | 1402 | 0.050 |
Why?
|
| Serine | 1 | 2004 | 826 | 0.050 |
Why?
|
| Myocardium | 2 | 2015 | 4776 | 0.050 |
Why?
|
| Cell Movement | 1 | 2012 | 5217 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 2020 | 402 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3617 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2256 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4204 | 0.040 |
Why?
|
| Angiomyolipoma | 1 | 2021 | 190 | 0.040 |
Why?
|
| Molsidomine | 1 | 2018 | 21 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2020 | 327 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2020 | 186 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1263 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 320 | 0.040 |
Why?
|
| Adenosine | 1 | 2004 | 825 | 0.040 |
Why?
|
| Male | 12 | 2021 | 350118 | 0.040 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 210 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3798 | 0.040 |
Why?
|
| Olfactory Perception | 1 | 2019 | 54 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 2018 | 121 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2018 | 49 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2003 | 1654 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 1072 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2023 | 2557 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 271 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1285 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 10943 | 0.040 |
Why?
|
| RNA, Viral | 2 | 2005 | 2902 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2005 | 2740 | 0.040 |
Why?
|
| Biological Products | 1 | 2006 | 860 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 1827 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2425 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2002 | 907 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 528 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
| Time Factors | 5 | 2017 | 40075 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1526 | 0.040 |
Why?
|
| Interferons | 1 | 2020 | 706 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 1419 | 0.030 |
Why?
|
| Ribonucleases | 1 | 2017 | 287 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 153 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1284 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1878 | 0.030 |
Why?
|
| Polyribonucleotide Nucleotidyltransferase | 1 | 2015 | 5 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2016 | 195 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2015 | 41 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2016 | 428 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2005 | 1886 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2021 | 5974 | 0.030 |
Why?
|
| Binding Sites | 1 | 2004 | 6114 | 0.030 |
Why?
|
| Muscles | 1 | 2020 | 1614 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2005 | 3610 | 0.030 |
Why?
|
| Phenotype | 2 | 2021 | 16365 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 7913 | 0.030 |
Why?
|
| Vincristine | 1 | 2016 | 1039 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2015 | 140 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2915 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2006 | 4554 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18029 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11366 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2003 | 3200 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 2012 | 93 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1821 | 0.030 |
Why?
|
| Gene Expression | 2 | 2003 | 7799 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5524 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 733 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2025 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2002 | 3494 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 213383 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1270 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1708 | 0.020 |
Why?
|
| Crystallins | 1 | 2011 | 75 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2015 | 686 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2012 | 821 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5867 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2020 | 3748 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2849 | 0.020 |
Why?
|
| Hypospadias | 1 | 2011 | 92 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2002 | 2104 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2011 | 262 | 0.020 |
Why?
|
| Caspases | 2 | 2003 | 928 | 0.020 |
Why?
|
| United States | 2 | 2009 | 69872 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 1782 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 466 | 0.020 |
Why?
|
| Female | 8 | 2020 | 380194 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 1351 | 0.020 |
Why?
|
| Organogenesis | 1 | 2011 | 222 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1678 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2109 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2010 | 227 | 0.020 |
Why?
|
| Edema | 1 | 2012 | 789 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 67 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2006 | 69 | 0.020 |
Why?
|
| Hippocampus | 1 | 2019 | 3675 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 424 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 711 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5456 | 0.020 |
Why?
|
| Inhalation Spacers | 1 | 2005 | 4 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
| DNA Damage | 2 | 2007 | 2432 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 229 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2005 | 206 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2020 | 4445 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2012 | 746 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2006 | 407 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4262 | 0.020 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 11 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2005 | 165 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 92 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2010 | 1530 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 63114 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1547 | 0.010 |
Why?
|
| Respirovirus Infections | 1 | 2002 | 50 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2002 | 102 | 0.010 |
Why?
|
| Granzymes | 1 | 2003 | 271 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 1369 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 163280 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.010 |
Why?
|
| Serpins | 1 | 2003 | 247 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1856 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1026 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 1288 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 743 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10481 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 1423 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4364 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 35136 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2541 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5756 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19905 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7474 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 9959 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7279 | 0.000 |
Why?
|